GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said ...

Over the past year, you may have heard about an experimental vaccine for pancreatic cancer. The news is good: The ...

The epidemic in Africa continues to grow, prompting fears of another outbreak in the U.S. But the vaccine is no longer free, ...

A fresh wave of disinformation about vaccines is flaring amid the 2024 campaign. The FDA's top vaccine official believes ...

HALIFAX - Nova Scotia’s Progressive Conservatives say that if re-elected Nov. 26 they will introduce a universal shingles ...

Older Americans are being urged to get the COVID-19 vaccine again, but it depends on when they received their last dose.

The aTIV vaccine provides better protection against influenza-related medical encounters than the HD-TIV vaccine in high-risk older adults.

Pediatricians are stunned by the possibility that vaccines proven to save kids’ lives could be banned under a second Trump ...

A study conducted by researchers from the CUNY Graduate School of Public Health and Health Policy (CUNY SPH) and the ...

Ongoing staff recruitment challenges, along with persistent vaccine reluctance, are the reasons why only 11% of Florida’s ...

“This annual vaccine — developed to target the strains that emerge each year to ensure utmost effectiveness — is safe, ...

Vaccine maker Moderna's chief executive officer Stephane Bancel will vacate his role as the company's chief commercial ...